Posts by: Marta Figueiredo

News

AbbVie, in collaboration with Neurocrine Biosciences, has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead candidate elagolix to treat heavy menstrual bleeding in ... Read more

April 17, 2018April 17, 2018

Neurontin May Be Effective for Endometriosis-associated Pelvic Pain, Study Suggests

News

Abnormally high expression of CACNA2D3, a gene involved in the process and transmission of pain, is associated with endometriosis, according to a recent study. This finding supports the use of Neurontin (gabapentin) — ... Read more

March 14, 2018March 14, 2018

Elagolix as Combo Therapy Lessens Heavy Bleeding Linked to Uterine Fibroids, 2nd Phase 3 Study Finds

News

Results from the second Phase 3 study evaluating the potential of elagolix to treat uterine fibroids show that, when combined with low-dose hormone therapy, the experimental therapy reduces heavy menstrual bleeding, AbbVie and Neurocrine Biosciences report. Endometriosis ... Read more